Loading…

Crosslinking Studies in Gelatin Capsules Treated with Formaldehyde and in Capsules Exposed to Elevated Temperature and Humidity

Incomplete in vitro capsule shell dissolution and subsequent drug release problems have recently received attention. A modified USP dissolution method was used to follow capsule shell dissolution, and a 2,4,6‐trinitrobenzenesulfonic acid (TNBS) assay was used to follow loss of ϵ‐amino groups to stud...

Full description

Saved in:
Bibliographic Details
Published in:Journal of pharmaceutical sciences 2001-01, Vol.90 (1), p.79-88
Main Authors: Ofner, Clyde M., Zhang, Yu‐E, Jobeck, Valerie C., Bowman, Bill J.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c4089-267532172bcbdb6e2d17dc773e56b0967e879ae82946bfabbc2067a96f921ea3
container_end_page 88
container_issue 1
container_start_page 79
container_title Journal of pharmaceutical sciences
container_volume 90
creator Ofner, Clyde M.
Zhang, Yu‐E
Jobeck, Valerie C.
Bowman, Bill J.
description Incomplete in vitro capsule shell dissolution and subsequent drug release problems have recently received attention. A modified USP dissolution method was used to follow capsule shell dissolution, and a 2,4,6‐trinitrobenzenesulfonic acid (TNBS) assay was used to follow loss of ϵ‐amino groups to study this shell dissolution problem postulated to be due to gelatin crosslinking. The dissolution problems were simulated using hard gelatin capsule (HGC) shells previously treated with formaldehyde to crosslink the gelatin. These methods were also used to study the effect of uncrosslinked HGC stored under stressed conditions (37 °C and 81% RH) with or without the presence of soft gelatin capsule shells (SGC). A 120 ppm formaldehyde treatment reduced gelatin shell dissolution to 8% within 45 min in water at 37 °C. A 200 ppm treatment reduced gelatin ϵ‐amino groups to 83% of the original uncrosslinked value. The results also support earlier reports of non‐amino group crosslinking by formaldehyde in gelatin. Under stressed conditions, HGC stored alone showed little change over 21 weeks. However, by 12 to 14 weeks, the HGC exposed to SGC showed a 23% decrease in shell dissolution and an 8% decrease in the number of ϵ‐amino groups. These effects on the stressed HGC are ascribed to a volatile agent from SGC shells, most likely formaldehyde, that crosslinked nearby HGC shells. This report also includes a summary of the literature on agents that reduce gelatin and capsule shell dissolution and the possible mechanisms of this not‐so‐simple problem. © 2001 Wiley‐Liss, Inc. and the American Pharmaceutical Association J Pharm Sci 90: 79–88, 2001
doi_str_mv 10.1002/1520-6017(200101)90:1<79::AID-JPS9>3.0.CO;2-L
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_70562412</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0022354916306955</els_id><sourcerecordid>70562412</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4089-267532172bcbdb6e2d17dc773e56b0967e879ae82946bfabbc2067a96f921ea3</originalsourceid><addsrcrecordid>eNqdkU9vEzEQxVcIRNPCV0ArISF62GB7s3acIqRqSdOiNEFK1B5H3vWEmu6fYO-2zYmvjpONAgcOiNPI9m_ePM8LgoSSPiWEfaAJIxEnVLxnhFBCTyUZ0Y9CjkbnV5-jL18X8lPcJ_10fsai6bOgd-CfBz3fz6I4Gcij4Ni574QQTpLkZXBEKeGDeEh7wc_U1s4Vpro31bdw0bTaoAtNFU6wUI2vqVq7tvB3S4uqQR0-muYuvKhtqQqNdxuNoap0-Cc5flrXzpNNHY4LfNh1LbFco1VNazv-si2NNs3mVfBipQqHr_f1JFhejJfpZTSdT67S82mUD8hQRoyLJGZUsCzPdMaRaSp0LkSMCc-I5AKHQiocMjng2UplWc4IF0rylWQUVXwSvOtk17b-0aJroDQux6JQFdatA0ESzgaUefC6A_PtXiyuYG1NqewGKIFtILBdMGwXDF0gIP0DCAngA4FtIBADgXQODKZe781-cJuVqH-r7RPwwNs9oFyuipVVVW7cgZPxkEjiqVlHPZoCN__u6S-WdmcvGHWCxjX4dBBU9h64iEUCt7MJLGfXC8Fub3b_uOl49CE9GLTgcoNVjtpYzBvQtfkvN_Ev4VXaSA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>70562412</pqid></control><display><type>article</type><title>Crosslinking Studies in Gelatin Capsules Treated with Formaldehyde and in Capsules Exposed to Elevated Temperature and Humidity</title><source>ScienceDirect®</source><source>Wiley Online Library All Journals</source><creator>Ofner, Clyde M. ; Zhang, Yu‐E ; Jobeck, Valerie C. ; Bowman, Bill J.</creator><creatorcontrib>Ofner, Clyde M. ; Zhang, Yu‐E ; Jobeck, Valerie C. ; Bowman, Bill J.</creatorcontrib><description>Incomplete in vitro capsule shell dissolution and subsequent drug release problems have recently received attention. A modified USP dissolution method was used to follow capsule shell dissolution, and a 2,4,6‐trinitrobenzenesulfonic acid (TNBS) assay was used to follow loss of ϵ‐amino groups to study this shell dissolution problem postulated to be due to gelatin crosslinking. The dissolution problems were simulated using hard gelatin capsule (HGC) shells previously treated with formaldehyde to crosslink the gelatin. These methods were also used to study the effect of uncrosslinked HGC stored under stressed conditions (37 °C and 81% RH) with or without the presence of soft gelatin capsule shells (SGC). A 120 ppm formaldehyde treatment reduced gelatin shell dissolution to 8% within 45 min in water at 37 °C. A 200 ppm treatment reduced gelatin ϵ‐amino groups to 83% of the original uncrosslinked value. The results also support earlier reports of non‐amino group crosslinking by formaldehyde in gelatin. Under stressed conditions, HGC stored alone showed little change over 21 weeks. However, by 12 to 14 weeks, the HGC exposed to SGC showed a 23% decrease in shell dissolution and an 8% decrease in the number of ϵ‐amino groups. These effects on the stressed HGC are ascribed to a volatile agent from SGC shells, most likely formaldehyde, that crosslinked nearby HGC shells. This report also includes a summary of the literature on agents that reduce gelatin and capsule shell dissolution and the possible mechanisms of this not‐so‐simple problem. © 2001 Wiley‐Liss, Inc. and the American Pharmaceutical Association J Pharm Sci 90: 79–88, 2001</description><identifier>ISSN: 0022-3549</identifier><identifier>EISSN: 1520-6017</identifier><identifier>DOI: 10.1002/1520-6017(200101)90:1&lt;79::AID-JPS9&gt;3.0.CO;2-L</identifier><identifier>PMID: 11064381</identifier><identifier>CODEN: JPMSAE</identifier><language>eng</language><publisher>New York: Elsevier Inc</publisher><subject>Aldehydes - chemistry ; amino group assay ; Biological and medical sciences ; Capsules - chemistry ; Coloring Agents - chemistry ; Cross-Linking Reagents - chemistry ; Formaldehyde - chemistry ; formaldehyde crosslinking in proteins ; Gelatin - chemistry ; gelatin crosslinking ; gelatin dissolution ; General pharmacology ; Humidity ; Light ; Medical sciences ; Pharmaceutical technology. Pharmaceutical industry ; Pharmacology. Drug treatments ; Temperature</subject><ispartof>Journal of pharmaceutical sciences, 2001-01, Vol.90 (1), p.79-88</ispartof><rights>2001 Wiley‐Liss, Inc. and the American Pharmaceutical Association</rights><rights>Copyright © 2001 Wiley‐Liss, Inc. and the American Pharmaceutical Association</rights><rights>2001 INIST-CNRS</rights><rights>Copyright 2001 Wiley-Liss, Inc. and the American Pharmaceutical Association J Pharm Sci 90: 79-88, 2001</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c4089-267532172bcbdb6e2d17dc773e56b0967e879ae82946bfabbc2067a96f921ea3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2F1520-6017%28200101%2990%3A1%3C79%3A%3AAID-JPS9%3E3.0.CO%3B2-L$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0022354916306955$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,1417,3549,4024,27923,27924,27925,45574,45575,45780</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=938090$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11064381$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ofner, Clyde M.</creatorcontrib><creatorcontrib>Zhang, Yu‐E</creatorcontrib><creatorcontrib>Jobeck, Valerie C.</creatorcontrib><creatorcontrib>Bowman, Bill J.</creatorcontrib><title>Crosslinking Studies in Gelatin Capsules Treated with Formaldehyde and in Capsules Exposed to Elevated Temperature and Humidity</title><title>Journal of pharmaceutical sciences</title><addtitle>J. Pharm. Sci</addtitle><description>Incomplete in vitro capsule shell dissolution and subsequent drug release problems have recently received attention. A modified USP dissolution method was used to follow capsule shell dissolution, and a 2,4,6‐trinitrobenzenesulfonic acid (TNBS) assay was used to follow loss of ϵ‐amino groups to study this shell dissolution problem postulated to be due to gelatin crosslinking. The dissolution problems were simulated using hard gelatin capsule (HGC) shells previously treated with formaldehyde to crosslink the gelatin. These methods were also used to study the effect of uncrosslinked HGC stored under stressed conditions (37 °C and 81% RH) with or without the presence of soft gelatin capsule shells (SGC). A 120 ppm formaldehyde treatment reduced gelatin shell dissolution to 8% within 45 min in water at 37 °C. A 200 ppm treatment reduced gelatin ϵ‐amino groups to 83% of the original uncrosslinked value. The results also support earlier reports of non‐amino group crosslinking by formaldehyde in gelatin. Under stressed conditions, HGC stored alone showed little change over 21 weeks. However, by 12 to 14 weeks, the HGC exposed to SGC showed a 23% decrease in shell dissolution and an 8% decrease in the number of ϵ‐amino groups. These effects on the stressed HGC are ascribed to a volatile agent from SGC shells, most likely formaldehyde, that crosslinked nearby HGC shells. This report also includes a summary of the literature on agents that reduce gelatin and capsule shell dissolution and the possible mechanisms of this not‐so‐simple problem. © 2001 Wiley‐Liss, Inc. and the American Pharmaceutical Association J Pharm Sci 90: 79–88, 2001</description><subject>Aldehydes - chemistry</subject><subject>amino group assay</subject><subject>Biological and medical sciences</subject><subject>Capsules - chemistry</subject><subject>Coloring Agents - chemistry</subject><subject>Cross-Linking Reagents - chemistry</subject><subject>Formaldehyde - chemistry</subject><subject>formaldehyde crosslinking in proteins</subject><subject>Gelatin - chemistry</subject><subject>gelatin crosslinking</subject><subject>gelatin dissolution</subject><subject>General pharmacology</subject><subject>Humidity</subject><subject>Light</subject><subject>Medical sciences</subject><subject>Pharmaceutical technology. Pharmaceutical industry</subject><subject>Pharmacology. Drug treatments</subject><subject>Temperature</subject><issn>0022-3549</issn><issn>1520-6017</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2001</creationdate><recordtype>article</recordtype><recordid>eNqdkU9vEzEQxVcIRNPCV0ArISF62GB7s3acIqRqSdOiNEFK1B5H3vWEmu6fYO-2zYmvjpONAgcOiNPI9m_ePM8LgoSSPiWEfaAJIxEnVLxnhFBCTyUZ0Y9CjkbnV5-jL18X8lPcJ_10fsai6bOgd-CfBz3fz6I4Gcij4Ni574QQTpLkZXBEKeGDeEh7wc_U1s4Vpro31bdw0bTaoAtNFU6wUI2vqVq7tvB3S4uqQR0-muYuvKhtqQqNdxuNoap0-Cc5flrXzpNNHY4LfNh1LbFco1VNazv-si2NNs3mVfBipQqHr_f1JFhejJfpZTSdT67S82mUD8hQRoyLJGZUsCzPdMaRaSp0LkSMCc-I5AKHQiocMjng2UplWc4IF0rylWQUVXwSvOtk17b-0aJroDQux6JQFdatA0ESzgaUefC6A_PtXiyuYG1NqewGKIFtILBdMGwXDF0gIP0DCAngA4FtIBADgXQODKZe781-cJuVqH-r7RPwwNs9oFyuipVVVW7cgZPxkEjiqVlHPZoCN__u6S-WdmcvGHWCxjX4dBBU9h64iEUCt7MJLGfXC8Fub3b_uOl49CE9GLTgcoNVjtpYzBvQtfkvN_Ev4VXaSA</recordid><startdate>200101</startdate><enddate>200101</enddate><creator>Ofner, Clyde M.</creator><creator>Zhang, Yu‐E</creator><creator>Jobeck, Valerie C.</creator><creator>Bowman, Bill J.</creator><general>Elsevier Inc</general><general>John Wiley &amp; Sons, Inc</general><general>Wiley</general><general>American Pharmaceutical Association</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>200101</creationdate><title>Crosslinking Studies in Gelatin Capsules Treated with Formaldehyde and in Capsules Exposed to Elevated Temperature and Humidity</title><author>Ofner, Clyde M. ; Zhang, Yu‐E ; Jobeck, Valerie C. ; Bowman, Bill J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4089-267532172bcbdb6e2d17dc773e56b0967e879ae82946bfabbc2067a96f921ea3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2001</creationdate><topic>Aldehydes - chemistry</topic><topic>amino group assay</topic><topic>Biological and medical sciences</topic><topic>Capsules - chemistry</topic><topic>Coloring Agents - chemistry</topic><topic>Cross-Linking Reagents - chemistry</topic><topic>Formaldehyde - chemistry</topic><topic>formaldehyde crosslinking in proteins</topic><topic>Gelatin - chemistry</topic><topic>gelatin crosslinking</topic><topic>gelatin dissolution</topic><topic>General pharmacology</topic><topic>Humidity</topic><topic>Light</topic><topic>Medical sciences</topic><topic>Pharmaceutical technology. Pharmaceutical industry</topic><topic>Pharmacology. Drug treatments</topic><topic>Temperature</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ofner, Clyde M.</creatorcontrib><creatorcontrib>Zhang, Yu‐E</creatorcontrib><creatorcontrib>Jobeck, Valerie C.</creatorcontrib><creatorcontrib>Bowman, Bill J.</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of pharmaceutical sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ofner, Clyde M.</au><au>Zhang, Yu‐E</au><au>Jobeck, Valerie C.</au><au>Bowman, Bill J.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Crosslinking Studies in Gelatin Capsules Treated with Formaldehyde and in Capsules Exposed to Elevated Temperature and Humidity</atitle><jtitle>Journal of pharmaceutical sciences</jtitle><addtitle>J. Pharm. Sci</addtitle><date>2001-01</date><risdate>2001</risdate><volume>90</volume><issue>1</issue><spage>79</spage><epage>88</epage><pages>79-88</pages><issn>0022-3549</issn><eissn>1520-6017</eissn><coden>JPMSAE</coden><abstract>Incomplete in vitro capsule shell dissolution and subsequent drug release problems have recently received attention. A modified USP dissolution method was used to follow capsule shell dissolution, and a 2,4,6‐trinitrobenzenesulfonic acid (TNBS) assay was used to follow loss of ϵ‐amino groups to study this shell dissolution problem postulated to be due to gelatin crosslinking. The dissolution problems were simulated using hard gelatin capsule (HGC) shells previously treated with formaldehyde to crosslink the gelatin. These methods were also used to study the effect of uncrosslinked HGC stored under stressed conditions (37 °C and 81% RH) with or without the presence of soft gelatin capsule shells (SGC). A 120 ppm formaldehyde treatment reduced gelatin shell dissolution to 8% within 45 min in water at 37 °C. A 200 ppm treatment reduced gelatin ϵ‐amino groups to 83% of the original uncrosslinked value. The results also support earlier reports of non‐amino group crosslinking by formaldehyde in gelatin. Under stressed conditions, HGC stored alone showed little change over 21 weeks. However, by 12 to 14 weeks, the HGC exposed to SGC showed a 23% decrease in shell dissolution and an 8% decrease in the number of ϵ‐amino groups. These effects on the stressed HGC are ascribed to a volatile agent from SGC shells, most likely formaldehyde, that crosslinked nearby HGC shells. This report also includes a summary of the literature on agents that reduce gelatin and capsule shell dissolution and the possible mechanisms of this not‐so‐simple problem. © 2001 Wiley‐Liss, Inc. and the American Pharmaceutical Association J Pharm Sci 90: 79–88, 2001</abstract><cop>New York</cop><pub>Elsevier Inc</pub><pmid>11064381</pmid><doi>10.1002/1520-6017(200101)90:1&lt;79::AID-JPS9&gt;3.0.CO;2-L</doi><tpages>10</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0022-3549
ispartof Journal of pharmaceutical sciences, 2001-01, Vol.90 (1), p.79-88
issn 0022-3549
1520-6017
language eng
recordid cdi_proquest_miscellaneous_70562412
source ScienceDirect®; Wiley Online Library All Journals
subjects Aldehydes - chemistry
amino group assay
Biological and medical sciences
Capsules - chemistry
Coloring Agents - chemistry
Cross-Linking Reagents - chemistry
Formaldehyde - chemistry
formaldehyde crosslinking in proteins
Gelatin - chemistry
gelatin crosslinking
gelatin dissolution
General pharmacology
Humidity
Light
Medical sciences
Pharmaceutical technology. Pharmaceutical industry
Pharmacology. Drug treatments
Temperature
title Crosslinking Studies in Gelatin Capsules Treated with Formaldehyde and in Capsules Exposed to Elevated Temperature and Humidity
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T18%3A33%3A44IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Crosslinking%20Studies%20in%20Gelatin%20Capsules%20Treated%20with%20Formaldehyde%20and%20in%20Capsules%20Exposed%20to%20Elevated%20Temperature%20and%20Humidity&rft.jtitle=Journal%20of%20pharmaceutical%20sciences&rft.au=Ofner,%20Clyde%20M.&rft.date=2001-01&rft.volume=90&rft.issue=1&rft.spage=79&rft.epage=88&rft.pages=79-88&rft.issn=0022-3549&rft.eissn=1520-6017&rft.coden=JPMSAE&rft_id=info:doi/10.1002/1520-6017(200101)90:1%3C79::AID-JPS9%3E3.0.CO;2-L&rft_dat=%3Cproquest_cross%3E70562412%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4089-267532172bcbdb6e2d17dc773e56b0967e879ae82946bfabbc2067a96f921ea3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=70562412&rft_id=info:pmid/11064381&rfr_iscdi=true